Addpharma Inc.

This study tests a new drug called AD-211 to find the best dose for reducing pain in people with knee osteoarthritis. About 200 participants will receive either AD-211 or a placebo, and researchers will measure pain changes over time. The goal is to ease symptoms, not cure the co…

This early-stage study will test a new experimental drug called AD-231 in 60 healthy adults aged 19 to 64. The goal is to see how the body processes the drug and whether it is safe when taken as a single pill versus taking its components separately. Participants will receive a si…

This early-stage study will compare two formulations of a drug for benign prostatic hyperplasia (enlarged prostate) in 44 healthy adult male volunteers. Participants will receive a single dose of each version under fasting conditions to measure safety and how the drug moves throu…

This early-stage study looks at how three experimental drugs (AD-231A, AD-231B, and AD-231C) interact in the body. It involves 55 healthy adults aged 19 to 64. The goal is to measure drug levels and check safety, not to treat any disease.

This early-stage study tests a new diabetes medicine called AD-123 in 50 healthy adults. Researchers want to see how safe it is and how the body processes it compared to taking its two components separately. The study does not involve treating diabetes directly.

This study tests two versions of a drug (AD-118 and AD-1181) in 70 healthy adults to see how they are processed in the body and if they are safe. Participants take a single dose of each version on separate days after fasting. The goal is to gather information, not to treat any di…

This early-stage study tests a new drug called AD-230 in 52 healthy adults aged 19 to 64. The goal is to measure how the drug moves through the body and to check for any safety concerns. Participants will receive the drug in two different ways (order decided by chance) so researc…